2015
DOI: 10.1002/cncy.21530
|View full text |Cite
|
Sign up to set email alerts
|

HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies

Abstract: BACKGROUND: Morphologic overlap between renal oncocytoma (RO) and chromophobe renal cell carcinoma (ChRCC) can pose diagnostic challenges, especially in biopsy samples in which tumor quantity may be limited, architectural features are not well represented, and gross examination is not possible. It has been demonstrated that immunohistochemistry (IHC) for HNF1a, HNF1b, and S100A1 are differentially expressed in RO and ChRCC in resection specimens. We evaluated the utility of these markers in FNA and core bio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
17
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(19 citation statements)
references
References 30 publications
2
17
0
Order By: Relevance
“…S100A1 was found to be differentially expressed in clear cell renal cell carcinoma and papillary renal cell carcinoma, and the differential expression may be a potentially useful marker to differentiate the chromophobe renal cell carcinoma from renal oncocytoma ( 7 , 8 ). S100A1 can also be used to differentiate other tumors ( 21 25 ).…”
Section: Discussionmentioning
confidence: 99%
“…S100A1 was found to be differentially expressed in clear cell renal cell carcinoma and papillary renal cell carcinoma, and the differential expression may be a potentially useful marker to differentiate the chromophobe renal cell carcinoma from renal oncocytoma ( 7 , 8 ). S100A1 can also be used to differentiate other tumors ( 21 25 ).…”
Section: Discussionmentioning
confidence: 99%
“…Thereafter, staining intensity was scored as follows: 0 (negative), 1 (weakly positive), 2 (moderately positive), and 3 (strongly positive). The immunostaining score, also known as staining index (SI), was calculated for each case by multiplying the percentage of positive cells with the staining intensity score, the resulting score is widely used in many malignant tumor studies [31, 32]. The immunohistochemistry scoring procedure was carried out to duplicate by two experienced pathologists to evaluate immunohistochemistry.…”
Section: Methodsmentioning
confidence: 99%
“…5 ). HNF1β and S100A1 are useful biomarker for distinguishing renal oncocytoma and chromophobe renal cell carcinoma [ 39 ].…”
Section: Resultsmentioning
confidence: 99%